A protocol for transitioning patients with heart failure and a left ventricular assist device to a stepdown unit from the ICU ...
Hypertrophic cardiomyopathy, also known as HCM or thick heart syndrome, is a genetic condition that causes your heart muscle ...
Zacks Investment Research on MSN21h
Bayer's sNDA for Kerendia Label Expansion Gets FDA's Priority ReviewBayer AG BAYRY recently announced that the FDA had accepted its supplemental new drug application (sNDA) seeking approval for ...
Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...
Regulators are expected to make a decision in the third quarter of 2025 on Kerendia to treat patients with heart failure with ...
News-Medical.Net on MSN5d
Study explores impact of severe tricuspid regurgitation in AFMR patientsAtrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback